OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Rheumatology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Update on antineutrophil cytoplasmic autoantibody vasculitis in children	191
Giant cell arteritis: update on pathogenesis and clinical implications	60
Polymyalgia rheumatica and giant cell arteritis: diagnosis and management	50
Urticarial vasculitis	46
Editorial introduction	46
Current approach to muscle imaging in myositis	39
Current views on lupus in children	39
Editorial introductions	34
Axial spondyloarthritis guidelines – aiming for maximum impact	31
Patient-reported outcomes in systemic sclerosis: insights into quality of life and disease burden	31
The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidence	31
Osteoporosis epidemiology using international cohorts	30
Juvenile Behçet syndrome: a contemporary view and differential diagnosis in pediatric practice	29
The gut microbiota in spondyloarthritis: an update	26
Comorbidities in idiopathic inflammatory myopathies: population-based evidence on risk subgroups and implications for delivery of care	26
Rheumatoid arthritis – the challenge of heterogeneity	25
A comprehensive review of systemic sclerosis–primary biliary cholangitis overlap: emerging evidence for a distinct clinical subtype	22
Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares, and enrich clinical trials in lupus	21
Composite measures to assess disease damage, disease severity and treatment response in systemic sclerosis clinical trials	20
Editorial introductions	19
Updates on translational and clinical research in systemic sclerosis	19
Editorial introductions	18
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis	17
VEXAS syndrome: an adult-onset autoinflammatory disorder with underlying somatic mutation	17
Ribosome dysfunction in osteoarthritis	17

Understanding the gastrointestinal microbiome in systemic sclerosis: methodological advancements and emerging research	16
Editorial introduction	16
Editorial introductions	16
Defining and managing flares in axial spondyloarthritis	15
Pathogenesis of skin damage in lupus: recent advances and future directions	14
Editorial introductions	14
The role of neutrophil extracellular traps in inflammatory rheumatic diseases	14
Management of cutaneous manifestations of systemic sclerosis: current approaches and emerging therapies	14
Insights into the pathogenic role of neutrophils in systemic lupus erythematosus	14
Health inequities in the rheumatic diseases of childhood	13
Nonsteroidal anti-inflammatory drugs and cardiovascular disease risk in spondyloarthritis-spectrum diseases	12
Animal models of vasculitis	12
Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis	12
Emerging synovial cell states in rheumatoid arthritis as potential therapeutic targets	12
Is it time to move on from pelvic radiography as the first-line imaging modality for suspected sacroiliitis?	12
Epidemiology of myositis	12
How common is vasculitis: what do population-based data tell us?	11
New developments related to lung complications in pediatric rheumatic disease	11
Editorial introductions	11
Environmental and occupational contributors to autoimmune, inflammatory, and musculoskeletal rheumatic disease: a review of emerging evidence and clinical implications	11
Chimeric antigen receptor T-cell therapy in rheumatology: B-cell depletion 2.0	11
Editorial introductions	11
Advances in the diagnosis and treatment of Sjögren disease	10
Investigating gout flares: beyond a definition	10
Diagnosis and management of primary heart involvement in systemic sclerosis	10
Exploring challenges in the management and treatment of inclusion body myositis	10
Vasculitis and the NLRP3 inflammasome	10
AI am the future: artificial intelligence in pediatric rheumatology	10
Editorial introduction	10
Biomarker discovery in psoriatic disease	10
Heart involvement in systemic sclerosis: emerging concepts	9
Management of postinfectious inflammatory arthritis	9
Decoding vascular dysfunction in systemic sclerosis: from endothelial damage to clinical implications	8
Update on streptococcal-associated rheumatic disease	8
Current management of giant cell arteritis and its complications	8
Advances in the diagnosis of multiorgan involvement in systemic sclerosis: a focus on MRI	8
Emerging biologic therapies for systemic lupus erythematosus	8
Gastrointestinal disease in systemic sclerosis: the neglected organ system?	8
Gastrointestinal involvement in systemic sclerosis: pathogenesis, assessment and treatment	8
Epidemiology of osteoarthritis: literature update 2022–2023	8